2017 annual financial data
Anika Therapeutics 2017 Operating margin
Anika Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was 40.32%.
Operating income was 45,729,000 USD and net income was 31,816,000 USD.
Operating cash flow was 40,812,000 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 113,420,000 USD
- Operating income
- 45,729,000 USD
- Net income
- 31,816,000 USD
- Operating cash flow
- 40,812,000 USD